OTCMKTS:CLSH CLS Holdings USA Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CLS Holdings USA Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.06 0.00 (0.00 %) (As of 09/29/2020 12:00 AM ET) Add Compare Share Today's Range$0.06Now: $0.06▼$0.0750-Day Range$0.06MA: $0.07▼$0.0852-Week Range$0.04Now: $0.06▼$0.27Volume12,058 shsAverage Volume113,086 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesShort InterestSocial Media CLS Holdings USA, Inc. focuses on the extraction and conversion of cannabinoids in the United States. The company extracts various cannabinoids from the marijuana plant and converts into concentrates, such as oils, waxes, edibles, and shatters. Its concentrates are used for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company also offers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories. CLS Holdings USA, Inc. was founded in 2014 and is based in Miami, Florida.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingCLS Holdings USA has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.10, CLS Holdings USA has a forecasted upside of 57.5% from its current price of $0.06.Amount of Analyst CoverageCLS Holdings USA has only been the subject of 1 research reports in the past 90 days. Previous Next 2.3 Community Rank Outperform VotesCLS Holdings USA has received 77 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCLS Holdings USA has received 87 “underperform” votes. (Add your “underperform” vote.)Community SentimentCLS Holdings USA has received 53.05% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about CLS Holdings USA and other stocks. Vote “Outperform” if you believe CLSH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CLSH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCLS Holdings USA does not currently pay a dividend.Dividend GrowthCLS Holdings USA does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CLS Holdings USA insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.11 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CLSH Previous Symbol CUSIPN/A CIKN/A Webwww.clsholdingsinc.com Phone888-438-9132Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $0.06 0.00 (0.00 %) (As of 09/29/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive CLSH News and Ratings via Email Sign-up to receive the latest news and ratings for CLSH and its competitors with MarketBeat's FREE daily newsletter. CLS Holdings USA (OTCMKTS:CLSH) Frequently Asked Questions How has CLS Holdings USA's stock been impacted by COVID-19 (Coronavirus)? CLS Holdings USA's stock was trading at $0.0913 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CLSH shares have decreased by 30.4% and is now trading at $0.0635. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of CLS Holdings USA? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CLS Holdings USA in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CLS Holdings USA. What price target have analysts set for CLSH? 2 Wall Street analysts have issued 12-month price targets for CLS Holdings USA's shares. Their forecasts range from $0.10 to $0.10. On average, they expect CLS Holdings USA's share price to reach $0.10 in the next twelve months. This suggests a possible upside of 57.5% from the stock's current price. View analysts' price targets for CLS Holdings USA. Who are some of CLS Holdings USA's key competitors? Some companies that are related to CLS Holdings USA include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), Auscann Group (AC8), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cannpal Animal Therapeutics (CP1), Cansortium (CNTMF) and Charlotte's Web (CWBHF). View all competitors. What other stocks do shareholders of CLS Holdings USA own? Based on aggregate information from My MarketBeat watchlists, some companies that other CLS Holdings USA investors own include Fulcrum Therapeutics (FULC), iAnthus Capital (ITHUF), KushCo (KSHB), VIVUS (VVUS), Processa Pharmaceuticals (PCSA), CymaBay Therapeutics (CBAY), Canopy Growth (CGC), Charlotte's Web (CWBHF), Kaleido Biosciences (KLDO) and Planet 13 (PLNHF). Who are CLS Holdings USA's key executives? CLS Holdings USA's management team includes the following people: Mr. Jeffrey I. Binder, Chairman & CEO (Age 72)Mr. Andrew J. Glashow, Pres, COO & Director (Age 56)Mr. Frank J. Tarantino, Chief Financial Officer (Age 60)Mr. Benjamin J. Sillitoe, Chief Exec. Officer of Oasis Cannabis (Age 42)Mr. Don Decatur, Chief Operating Officer of CLS Nevada, Inc. (Age 35) What is CLS Holdings USA's stock symbol? CLS Holdings USA trades on the OTCMKTS under the ticker symbol "CLSH." How do I buy shares of CLS Holdings USA? Shares of CLSH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is CLS Holdings USA's stock price today? One share of CLSH stock can currently be purchased for approximately $0.06. What is CLS Holdings USA's official website? The official website for CLS Holdings USA is www.clsholdingsinc.com. How can I contact CLS Holdings USA? The company can be reached via phone at 888-438-9132. This page was last updated on 9/30/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
